Homocysteine and fracture prevention

JAMA

Volumn 293, Issue 9, 2005, Pages 1121-1122

  Van Meurs, Joyce B J ^a   Uitterlinden, André G ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; DRUG DERIVATIVE; MECOBALAMIN;

BONE DENSITY; CLINICAL TRIAL; COGNITIVE DEFECT; CYANOCOBALAMIN DEFICIENCY; EDITORIAL; FRACTURE; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; INCIDENCE; OSTEOPOROSIS; PRIORITY JOURNAL; RISK REDUCTION; STROKE; VITAMIN SUPPLEMENTATION; BLOOD; CEREBROVASCULAR ACCIDENT; DIET SUPPLEMENTATION; NOTE; RISK FACTOR;

CEREBROVASCULAR ACCIDENT; DIETARY SUPPLEMENTS; FOLIC ACID; HIP FRACTURES; HOMOCYSTEINE; HUMANS; RISK FACTORS; VITAMIN B 12;

EID: 14144255132     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.293.9.1121     Document Type: Editorial

References (21)

1. Christodoulou C, Cooper C. What is osteoporosis? Postgrad Med J. 2003;79:133-138.
2. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med. 2004;350:2033-2041.
3. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350:2042-2049.
4. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA. 2005;293:1082-1088.
5. Kanis JA, Johnell O, De Laet C, Jonsson B, Oden A, Ogelsby AK. International variations in hip fracture probabilities: implications for risk assessment. J Bone Miner Res. 2002;17:1237-1244.
6. Garcia A, Zanibbi K. Homocysteine and cognitive function in elderly people. CMAJ. 2004;171:897-904.
7. Mangoni AA, Jackson SH. Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med. 2002;112:556-565.
8. Wolters M, Ströhle A, Hahn A. Cobalamin: a critical vitamin in the elderly. Prev Med. 2004;39:1256-1266.
9. Goerss JB, Kim CH, Atkinson EJ, Eastell R, O'Fallon WM, Melton LJ III. Risk of fractures in patients with pernicious anemia. J Bone Miner Res. 1992;7:573-579.
10. Dhonukshe-Rutten RA, Lips M, de Jong N, et al. Vitamin B-12 status is associated with bone mineral content and bone mineral density in frail elderly women but not in men. J Nutr. 2003;133:801-807.
11. Tucker KL, Hannan MT, Qiao N, et al. Low plasma vitamin B(12) is associated with lower BMD: the Framingham Osteoporosis Study. J Bone Miner Res. 2005;20:152-158.
12. Carmel R, Lau KH, Baylink DJ, Saxena S, Singer FR. Cobalamin and osteoblast-specific proteins. N Engl J Med. 1988;319:70-75.
13. Kim GS, Kim CH, Park JY, Lee KU, Park CS. Effects of vitamin B12 on cell proliferation and cellular alkaline phosphatase activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism. 1996;45:1443-1446.
14. McKusick VA. Heritable Disorders of Connective Tissue. 3rd ed. St Louis, Mo: Mosby; 1966:155.
15. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-linking in patients with homocystinuria. Biochim Biophys Acta. 1996;1315:159-162.
16. Davey Smith G, Ebrahim S. "Mendelian randomization": can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 2003;32:1-22.
17. Casas JP, Bautista LE, Smeeth L, Sharma P, Hingorani AD. Homocysteine and stroke: evidence on a causal link from mendelian randomisation. Lancet. 2005;365:224-232.
18. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet. 1995;10:111-113.
19. Miyao M, Morita H, Hosoi T, et al. Association of methylenetetrahydrofolate reductase (MTHFR) polymorphism with bone mineral density in postmenopausal Japanese women. Calcif Tissue Int. 2000;66:190-194.
20. McLean RR, Karasik D, Selhub J, et al. Association of a common polymorphism in the methylenetetrahydrofolate reductase (MTHFR) gene with bone phenotypes depends on plasma folate status. J Bone Miner Res. 2004;19:410-418.
21. Abrahamsen B, Madsen JS, Tofteng CL, et al. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish Osteoporosis Prevention Study. J Bone Miner Res. 2003;18:723-729.